Kenvue Inc. (KVUE) Stock Price

KVUEStockS&P 500

$18.91+34.02%52W

Market Cap$36.32B

P/E24.71x

PEG Ratio1.43

Div yield4.47%

Beta0.45

KVUE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-1.10%

Price vs S&P 500 (4W)8.34%

PEG Ratio1.43

VGM Score58.66

P/E Ratio (Annual)24.71x

Indicated Dividend Yield (Annual)4.47%

P/CF (Annual)16.53x

Book Value / Share (Quarterly)$5.50

P/TBV (Annual)15.90x

Indicated Dividend (Annual)$0.84

Revenue Growth (3Y)0.39%

Cash Flow / Share (Quarterly)$1.00

Payout Ratio (TTM)96.02%

Price vs S&P 500 (YTD)-2.30%

Gross Margin (TTM)58.64%

Net Profit Margin (TTM)10.76%

EPS (TTM)$0.86

10-Day Avg Trading Volume21.78M

EPS Excl Extra (TTM)$0.86

Revenue Growth (5Y)0.89%

EPS (Annual)$0.76

Dividend / Share (Annual)$0.83

ROI (Annual)7.62%

Gross Margin (Annual)58.62%

Net Profit Margin (5Y Avg)10.92%

Cash / Share (Quarterly)$0.58

P/E Basic Excl Extra (TTM)21.91x

Revenue Growth QoQ (YoY)3.02%

P/E Normalized (Annual)24.71x

ROA (Last FY)5.43%

Revenue Growth TTM (YoY)1.76%

EBITD / Share (TTM)$1.66

ROE (5Y Avg)11.91%

Operating Margin (TTM)17.07%

Cash Flow / Share (Annual)$0.90

P/B Ratio3.44x

P/B Ratio (Quarterly)3.47x

Net Income / Employee (Annual)$67,500

EV / Revenue (TTM)2.84x

Net Interest Coverage (TTM)5.70x

ROA (TTM)6.15%

EPS Growth QoQ (YoY)8.86%

EV / EBITDA (TTM)13.67x

EPS Incl Extra (Annual)$0.76

Current Ratio (Annual)0.96x

Quick Ratio (Quarterly)0.64x

3-Month Avg Trading Volume21.82M

52-Week Price Return34.02%

EV / Free Cash Flow (Annual)25.37x

P/E Incl Extra (TTM)21.91x

Revenue / Employee (TTM)$707,400

Tangible BV / Share (Quarterly)$1.12

P/S Ratio (Annual)2.40x

Asset Turnover (Annual)0.56x

52-Week High$20.13

Operating Margin (5Y Avg)16.32%

EPS Excl Extra (Annual)$0.76

CapEx CAGR (5Y)15.71%

26-Week Price Return8.80%

Quick Ratio (Annual)0.61x

13-Week Price Return-0.37%

Total Debt / Equity (Annual)0.79x

Current Ratio (Quarterly)1.01x

Enterprise Value$43.69B

Revenue / Share Growth (5Y)0.52%

Asset Turnover (TTM)0.57x

Revenue / Employee (Annual)$694,400

Inventory Turnover (Annual)3.84x

Pretax Margin (Annual)13.22%

Cash / Share (Annual)$0.55

3-Month Return Std Dev20.55%

Gross Margin (5Y Avg)57.11%

Net Income / Employee (TTM)$76,100

ROE (Last FY)13.66%

Net Interest Coverage (Annual)6.33x

EPS Basic Excl Extra (Annual)$0.76

P/FCF (TTM)18.98x

Receivables Turnover (TTM)6.41x

EV / Free Cash Flow (TTM)22.83x

Total Debt / Equity (Quarterly)0.80x

EPS Incl Extra (TTM)$0.86

Receivables Turnover (Annual)6.65x

ROI (TTM)8.59%

P/S Ratio (TTM)2.36x

Pretax Margin (5Y Avg)14.73%

Revenue / Share (Annual)$7.86

Tangible BV / Share (Annual)$1.08

Forward P/E14.41x

Free OCF CAGR (5Y)-11.48%

Price vs S&P 500 (52W)18.49%

P/E Ratio (TTM)21.91x

EPS Growth TTM (YoY)17.17%

Year-to-Date Return9.62%

5-Day Price Return6.06%

EPS Normalized (Annual)$0.76

ROA (5Y Avg)6.07%

Net Profit Margin (Annual)9.72%

Month-to-Date Return7.08%

EBITD / Share (Annual)$1.54

EPS Growth (3Y)-11.57%

Operating Margin (Annual)15.96%

LT Debt / Equity (Annual)0.64x

P/CF (TTM)15.62x

ROI (5Y Avg)8.43%

P/E Excl Extra (TTM)21.91x

LT Debt / Equity (Quarterly)0.67x

EPS Basic Excl Extra (TTM)$0.86

P/TBV (Quarterly)17.05x

Payout Ratio (Annual)107.55%

P/B Ratio (Annual)3.06x

Dividend / Share (TTM)$0.83

Inventory Turnover (TTM)3.64x

Pretax Margin (TTM)14.43%

Book Value / Share (Annual)$5.62

Price vs S&P 500 (13W)-3.05%

Dividend Yield (TTM)4.38%

Beta0.45x

P/FCF (Annual)21.09x

Revenue / Share (TTM)$8.01

ROE (TTM)15.58%

52-Week Low$14.02

vGradeC

gGradeC

mGradeA

vgmGradeC

KVUE Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	$0.32	$0.31	-2.82%(-$0.01)
Q1 2026	May 7, 2026	$0.26	$0.32	+23.03%(+$0.06)
Q4 2025	Feb 17, 2026	$0.22	$0.27	+21.24%(+$0.05)
Q3 2025	Nov 3, 2025	$0.26	$0.28	+5.72%(+$0.02)
Q2 2025	Aug 7, 2025	$0.28	$0.29	+2.22%(+$0.01)

KVUE Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

2.72

3.40

Industry Peers — Cosmetics & Toiletries(22)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
KVUEKenvue Inc.	C	C	A	2.4x	1.8%	58.6%	—	$18.91
CLColgate-Palmolive Company	C	C	B	3.6x	5.2%	60.4%	-3.5%	$94.11
HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	3.0x	1.2%	65.5%	8.3%	$10.13
ELThe Estee Lauder Companies Inc. Class A	D	D	A	2.5x	5.1%	75.5%	-42.3%	$104.54
ELFe.l.f. Beauty, Inc.	D	B	A	3.8x	31.2%	74.4%	30.1%	$113.54
IPARInterparfums, Inc. Common Stock	C	B	B	2.5x	2.9%	55.8%	34.2%	$115.69
COTYCOTY INC	B	C	B	0.5x	-1.5%	62.9%	—	$3.20
EPCEdgewell Personal Care Company	B	D	B	0.6x	-7.0%	41.1%	-15.5%	$27.91
ODDODDITY Tech Ltd. Class A Ordinary Shares	C	C	B	1.5x	-9.7%	70.0%	50.4%	$22.43
YSGYatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares	A	C	C	0.4x	-1.6%	77.4%	—	$2.58
PTNMPitanium Limited Class A Ordinary shares	—	—	B	—	—	—	—	$10.39
WALDWaldencast plc Class A Ordinary Share	B	F	C	0.4x	-26.6%	66.1%	—	$0.88
SLSNSolesence, Inc. Common Stock	D	D	C	1.1x	-14.1%	26.9%	-0.8%	$0.90
AXILAXIL Brands, Inc.	B	B	B	1.2x	10.3%	72.4%	—	$5.46
UGUnited-Guardian, Inc.	B	D	B	2.8x	3.2%	46.9%	-8.6%	$6.84
CABRCaring Brands, Inc. Common Stock	—	—	C	—	—	—	—	$1.22
BNKKBonk, Inc. Common Stock	A	A	D	1.0x	2362.4%	55.4%	—	$1.21
BIOTInstinct Bio Technical Company Holdings Inc. Ordinary Shares	—	C	B	—	—	—	—	$0.23
YCBDcbdMD, Inc. Common Stock	B	C	D	0.2x	10.0%	57.7%	—	$0.36
BIOTWInstinct Bio Technical Company Holdings Inc. Warrants	—	—	A	—	—	—	—	$0.01
EMPGEmpro Group Inc. Ordinary shares	—	—	A	—	—	—	—	$0.00
OLPXOlaplex Holdings, Inc. Common Stock	C	D	B	3.3x	1.1%	71.2%	-20.8%	$0.00
WALDWWaldencast plc Warrant	—	—	F	—	—	—	—	$0.00

About Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company with over $15 billion in annual revenue, offering products across pain management, oral care, cough and cold care, and skincare through iconic brands including Tylenol, Listerine, Aveeno, and Neutrogena. Spun off from Johnson & Johnson in May 2023, the company agreed to be acquired by Kimberly-Clark in November 2025, with the transaction expected to close in the second half of 2026.